Bank of New York Mellon
NRXS icon

Bank of New York Mellon’s Neuraxis NRXS Stock Holding History

Bank of New York Mellon’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-26,001
Closed -$98.8K – 4361
2023
Q3 		$98.8K Buy
+26,001
New +$120K ﹤0.01% 4080

Other funds holding NRXS

Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon's NRXS Position: Q4 2023 in Review

Bank of New York Mellon sold out of Neuraxis (NRXS) in Q4 2023, closing a stake of 26,001 shares — an estimated $98.8K sold.

Bank of New York Mellon first reported a position in NRXS in Q3 2023 and held it in 1 quarter. The position peaked at $98.8K in Q3 2023. 7 funds tracked by Wall St. Rank hold NRXS as of Q4 2023.

  • Bank of New York Mellon reported no remaining Neuraxis position as of Q4 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 26,001 Neuraxis shares in Q4 2023, an estimated $98.8K.
  • Bank of New York Mellon first reported a position in Neuraxis in Q3 2023 and held it in 1 quarter.
  • Bank of New York Mellon's Neuraxis position peaked at $98.8K in Q3 2023.
  • 7 funds tracked by Wall St. Rank held Neuraxis as of Q4 2023.

Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.